| Authors: |
Vervoort BMT; Princess Máxima Center for Pediatric Oncology, Utrecht, 3584 CS., Butler M; Princess Máxima Center for Pediatric Oncology, Utrecht, 3584 CS., Grünewald KJT; Princess Máxima Center for Pediatric Oncology, Utrecht, 3584 CS., Schenau DSVI; Princess Máxima Center for Pediatric Oncology, Utrecht, 3584 CS., Tee TM; Princess Máxima Center for Pediatric Oncology, Utrecht, 3584 CS., Lucas L; Netherlands Cancer Institute, Amsterdam., Huitema ADR; Princess Máxima Center for Pediatric Oncology, Utrecht, 3584 CS, the Netherlands; Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht., Boer JM; Princess Máxima Center for Pediatric Oncology, Utrecht, 3584 CS., Bornhauser BC; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, CH-8008., Bourquin JP; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, CH-8008., Hoogerbrugge PM; Princess Máxima Center for Pediatric Oncology, Utrecht, 3584 CS., Van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam., Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, 3584 CS, the Netherlands; Department of Genetics, Utrecht University Medical Center, Utrecht University, Utrecht The Netherlands., Van der Meer LT; Princess Máxima Center for Pediatric Oncology, Utrecht, 3584 CS., Van Leeuwen FN; Princess Máxima Center for Pediatric Oncology, Utrecht, 3584 CS. F.N.vanleeuwen@prinsesmaximacentrum.nl. |